Literature DB >> 9617640

Tc-99m tetrofosmin myocardial SPECT perfusion imaging: comparison of rest-stress and stress-rest protocols.

M M Boomsma1, M G Niemeyer, E E van der Wall, B L van Eck-Smit, A H Zwinderman, J H Boomsma, E K Pauwels.   

Abstract

AIM: The purpose of this study was to evaluate the diagnostic value of Tc-99m tetrofosmin SPECT myocardial perfusion scintigraphy rest/stress and stress/rest protocols for the assessment of coronary artery disease (CAD).
METHODS: 65 patients underwent both rest and stress SPECT imaging in a one-day protocol and coronary angiography within 2 months before or after scintigraphy. Scintigraphic data was obtained according to two different protocols; 1) rest-stress (n = 18) and 2) stress-rest (n = 47).
RESULTS: Scintigraphic evidence for myocardial ischaemia was found in 36 patients (55%). The overall sensitivity to detect CAD (> 50% luminal stenosis) was 94% (34/36), specificity 66% (19/24), positive predictive value 77%, negative predictive value 90%. The sensitivity to detect CAD for protocols 1 and 2 were 100% and 93%, specificity 56% and 70%, positive predictive value 69% and 81% and negative predictive value 100% and 88%, respectively. The left anterior descending coronary artery showed a sensitivity (overall, protocol 1 & 2) of 78%, 75% (3/4) and 79% (15/19) and a specificity of 71%, 64% (9/14) and 75% (21/28). The right coronary artery showed a sensitivity (overall, protocol 1 & 2) of 91%, 100% (6/6) and 88% (14/16) and a specificity of 70%, 92% (11/12) and 61% (19/31). The left circumflex coronary artery showed a sensitivity (overall, protocol 1 & 2) of 50%, 67% (2/3) and 46% (6/13) and a specificity of 94%, 100% (15/15) and 91% (31/34).
CONCLUSION: Tc-99m tetrofosmin appears to be a valuable tool in predicting significant CAD. The sensitivity and the positive predictive value are high, making this test highly appropriate for the diagnosis of CAD. The diagnostic value of the individual coronary arteries is high to moderate. No significant differences were found between both protocols.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9617640     DOI: 10.1023/a:1005930200119

Source DB:  PubMed          Journal:  Int J Card Imaging        ISSN: 0167-9899


  21 in total

1.  SPECT versus planar 99mTc-sestamibi myocardial scintigraphy: comparison of accuracy and impact on patient management in chronic ischemic heart disease.

Authors:  M J Cramer; E E van der Wall; J F Verzijlbergen; W Jaarsma; M G Niemeyer; A H Zwindrman; C A Ascoop; E K Pauwels
Journal:  Q J Nucl Med       Date:  1997-03

2.  Efficacy of intravenous dipyridamole with exercise in thallium-201 myocardial perfusion scintigraphy.

Authors:  G J Laarman; A V Bruschke; F J Verzijlbergen; E T Bal; E E van der Wall; C A Ascoop
Journal:  Eur Heart J       Date:  1988-11       Impact factor: 29.983

3.  Exercise graded by heart rate in electrocardiographic testing for angina pectoris.

Authors:  L T Sheffield; J H Holt; T J Reeves
Journal:  Circulation       Date:  1965-10       Impact factor: 29.690

4.  Is quantitative analysis superior to visual analysis of planar thallium 201 myocardial exercise scintigraphy in the evaluation of coronary artery disease? Analysis of a prospective clinical study.

Authors:  M G Niemeyer; G J Laarman; E E van der Wall; M J Cramer; F J Verzijlbergen; A H Zwinderman; C A Ascoop; E K Pauwels
Journal:  Eur J Nucl Med       Date:  1990

5.  Myocardial SPET imaging with 99Tcm-tetrofosmin in clinical practice: comparison of a 1 day and a 2 day imaging protocol.

Authors:  B L van Eck-Smit; S Poots; A H Zwinderman; A V Bruschke; E K Pauwels; E E van der Wall
Journal:  Nucl Med Commun       Date:  1997-01       Impact factor: 1.690

6.  Reduced variability of interpretation and improved image quality with a technetium 99m myocardial perfusion agent: comparison of thallium 201 and technetium 99m-labeled tetrofosmin.

Authors:  R C Hendel; M A Parker; F J Wackers; P Rigo; A Lahiri; B L Zaret
Journal:  J Nucl Cardiol       Date:  1994 Nov-Dec       Impact factor: 5.952

7.  Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group.

Authors:  B L Zaret; P Rigo; F J Wackers; R C Hendel; S H Braat; A S Iskandrian; B S Sridhara; D Jain; R Itti; A N Serafini
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

8.  Myocardial tomography using technetium-99m-tetrofosmin to evaluate coronary artery disease.

Authors:  N Tamaki; N Takahashi; M Kawamoto; T Torizuka; E Tadamura; Y Yonekura; K Okuda; R Nohara; S Sasayama; J Konishi
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

9.  Technetium-99m-tetrofosmin to assess myocardial blood flow: experimental validation in an intact canine model of ischemia.

Authors:  A J Sinusas; Q Shi; M T Saltzberg; P Vitols; D Jain; F J Wackers; B L Zaret
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

10.  Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols.

Authors:  S H Braat; B Leclercq; R Itti; A Lahiri; B Sridhara; P Rigo
Journal:  J Nucl Med       Date:  1994-10       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.